Prevalence and Risk Factors of Postacute Sequelae of COVID-19 in Adults With Systemic Autoimmune Rheumatic Diseases.
Mayan S TelesJanetta BrundageTeresa Po-Yu ChiangJennifer L AlejoNicolas HenriquezRachel S WallworkLisa Christopher-StineAllan B MassieDorry L SegevCaoilfhionn Marie ConnollyJulie J PaikWilliam A WerbelPublished in: The Journal of rheumatology (2024)
In a large, real-world cohort, 29.8% of persons with systemic autoimmune disease reported PASC, often affecting QOL. Preceding vaccination may reduce PASC, whereas multiple infections may increase risk, supporting ongoing booster vaccine campaigns and efforts to limit breakthrough infections.